Bespoke Extracts, Inc. GAAP EPS of -$0.01, revenue of $467M

Published 6 hours ago Positive
Bespoke Extracts, Inc. GAAP EPS of -$0.01, revenue of $467M
* Bespoke Extracts, Inc. press release [https://seekingalpha.com/pr/20303677-bespoke-extracts-inc-reports-third-quarter-2025-results-the-joint-company-scales-colorado] (OTCQB:BSPK [https://seekingalpha.com/symbol/BSPK]): Q3 GAAP EPS of -$0.01.
* Revenue of $467M.

*
Fourth Quarter 2025 Outlook

* Revenue: Projected between $425,000 and $500,000, up 41%–66% year-over-year, driven by continued demand for Fresh Joints and expansion of Doobskis and Dutch Blunts.
* Gross Margin: The company expects to maintain approximately 50% blended gross margins across product lines through disciplined cost management and increased production throughput.
* Innovation: Two new Company owned brands are set to launch in Q4, designed to capture adjacent market segments with highly competitive price-to-quality positioning.
* Expansion: Bespoke continues to evaluate opportunities to replicate The Joint Company model in additional regulated markets, including Massachusetts and New York.

MORE ON BESPOKE EXTRACTS, INC.

* Seeking Alpha’s Quant Rating on Bespoke Extracts, Inc. [https://seekingalpha.com/symbol/BSPK/ratings/quant-ratings]
* Financial information for Bespoke Extracts, Inc. [https://seekingalpha.com/symbol/BSPK/income-statement]